financetom
Business
financetom
/
Business
/
Update: Aris Mining Up 8% as Q4 Adjusted Earnings Jump; Expanding Capacity at the Marmato Project by 25%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Aris Mining Up 8% as Q4 Adjusted Earnings Jump; Expanding Capacity at the Marmato Project by 25%
Mar 13, 2025 9:32 AM

12:03 PM EDT, 03/13/2025 (MT Newswires) -- (Updates shares.)

Aris Mining ( ARMN ) on Wednesday said its fourth-quarter adjusted earnings rose as it achieved its highest production of the year.

Adjusted earnings, excluding most one-time items, climbed to to US$24.7 million, or US$0.14 per share, from US$11.8 million, or US$0.09, in the year-prior quarter.

The company swung to a net profit of US$21.7 million, or US$0.13, from a loss of US$5.9 million, or US$0.04. Adjusted EBITDA also increased to US$55.6 million from US$39.7 million.

The company produced 57,364 ounces of gold, down from 61,052 ounces in the year-ago period, but was the highest quarterly production in 2024.

For 2025, Aris expects to produce 210,000 to 250,000 ounces of gold, up from 2024 production of 187,583 ounces.

Aris also plans to expand the capacity of the Lower Mine at the Marmato project in Colombia by 25% to 5,000 tonnes per day, up from the initial 4,000 tpd. The updated cost to complete construction is US$290 million. The production ramp-up is scheduled to start in the second half of 2026.

Aris shares were last seen up $0.48 to $6.32 on the Toronto Stock Exchange.

Price: 6.32, Change: +0.48, Percent Change: +8.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
I-Mab to Acquire Bridge Health Biotech
I-Mab to Acquire Bridge Health Biotech
Jul 17, 2025
07:30 AM EDT, 07/17/2025 (MT Newswires) -- I-Mab ( IMAB ) said Thursday it has agreed to buy Bridge Health Biotech for an upfront payment of $1.8 million, plus $1.2 million in non-contingent payments through 2027. Bridge Health Biotech shareholders may also be entitled to future milestone payments of up to about $3.9 million, I-Mab ( IMAB ) said. The...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Wallbridge Mining Launches Phase Two Drilling at Martiniere Gold Project in Quebec
Wallbridge Mining Launches Phase Two Drilling at Martiniere Gold Project in Quebec
Jul 17, 2025
07:30 AM EDT, 07/17/2025 (MT Newswires) -- Wallbridge Mining ( WLBMF ) said Thursday that it commenced the second phase of drilling at the Martiniere gold project in Quebec. The phase two campaign will follow up on the positive results returned from phase one drilling of 7,225 meters that was completed in May. The company plans to complete a total...
Rocket Pharmaceuticals' Drug Candidate for Heart Condition Receives FDA RMAT Designation
Rocket Pharmaceuticals' Drug Candidate for Heart Condition Receives FDA RMAT Designation
Jul 17, 2025
07:30 AM EDT, 07/17/2025 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Thursday that the US Food and Drug Administration has granted regenerative medicine advanced therapy, or RMAT, designation to RP-A601, the company's experimental gene therapy for PKP2-arrhythmogenic cardiomyopathy, a heart condition. The designation was based on safety and efficacy data from a phase 1 trial. The designation offers...
Copyright 2023-2026 - www.financetom.com All Rights Reserved